Navigation Links
New research on pre-eclampsia in mice may have important implications for humans
Date:7/27/2008
Post Your Comments:
*Name:
*Comment:
*Email:
Breaking Biology News(10 mins):Self-destructing bacteria improve renewable biofuel production 2Self-destructing bacteria improve renewable biofuel production 3Researchers demonstrate nanoscale X-ray imaging of bacterial cells 2$2.4 million stimulus fuels effort to regenerate injured spinal cords 2$2.4 million stimulus fuels effort to regenerate injured spinal cords 3$2.4 million stimulus fuels effort to regenerate injured spinal cords 4PHOENIX AHF Magic Johnson HIV Testing Caravan 26 Southwest Center for HIV AIDS to Host Free HIV Testing Event at Off Chute Too 48214 1PHOENIX AHF Magic Johnson HIV Testing Caravan 26 Southwest Center for HIV AIDS to Host Free HIV Testing Event at Off Chute Too 48214 2PHOENIX AHF Magic Johnson HIV Testing Caravan 26 Southwest Center for HIV AIDS to Host Free HIV Testing Event at Off Chute Too 48214 3PHOENIX AHF Magic Johnson HIV Testing Caravan 26 Southwest Center for HIV AIDS to Host Free HIV Testing Event at Off Chute Too 48214 4PHOENIX AHF Magic Johnson HIV Testing Caravan 26 Southwest Center for HIV AIDS to Host Free HIV Testing Event at Off Chute Too 48214 5PHOENIX AHF Magic Johnson HIV Testing Caravan 26 Southwest Center for HIV AIDS to Host Free HIV Testing Event at Off Chute Too 48214 6VA Awards 243 7 Million for New Hampshire Veterans Home 48212 1Caliper Life Sciences to Webcast Investor Session of Open House 12528 1Caliper Life Sciences to Webcast Investor Session of Open House 12528 2
Breaking Biology Technology:Dip ordinary paper into ink infused with nanotubes and nanowires to create an instant battery 2Surety Leads Web Symposium to Address Data Integrity Issues in Bio-Sciences Industry 2AEterna Zentaris Partner, Keryx, Reports Updated Phase 1/2 Data, Including New Survival Data, on Perifosine (KRX-0401) in the Treatment of Advanced Multiple Myeloma at the 51st Annual Meeting of the American Society of Hematology 2AEterna Zentaris Partner, Keryx, Reports Updated Phase 1/2 Data, Including New Survival Data, on Perifosine (KRX-0401) in the Treatment of Advanced Multiple Myeloma at the 51st Annual Meeting of the American Society of Hematology 3AEterna Zentaris Partner, Keryx, Reports Updated Phase 1/2 Data, Including New Survival Data, on Perifosine (KRX-0401) in the Treatment of Advanced Multiple Myeloma at the 51st Annual Meeting of the American Society of Hematology 4AEterna Zentaris Partner, Keryx, Reports Updated Phase 1/2 Data, Including New Survival Data, on Perifosine (KRX-0401) in the Treatment of Advanced Multiple Myeloma at the 51st Annual Meeting of the American Society of Hematology 5AEterna Zentaris Partner, Keryx, Reports Updated Phase 1/2 Data, Including New Survival Data, on Perifosine (KRX-0401) in the Treatment of Advanced Multiple Myeloma at the 51st Annual Meeting of the American Society of Hematology 6ATS Medical Announces CE Mark Approval for the ATS 3f Enable Bioprosthesis 2ATS Medical Announces CE Mark Approval for the ATS 3f Enable Bioprosthesis 3ATS Medical Announces CE Mark Approval for the ATS 3f Enable Bioprosthesis 4